Elsevier Inc.

SHERPA: Unknown

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Dahi
    Dahi
  4. Shah
    Shah
  5. Papanicolaou
    Papanicolaou
  6. Boelens
    Boelens
  7. Politikos
    Politikos
  8. Ponce
    Ponce
  9. Scordo
    Scordo
  10. Lin
    Lin

Groups

  1. Department of Medicine (151)
  2. Hematologic Malignancies, Division of (126)
  3. Center for Hematologic Malignancies (120)
  4. Bone Marrow Transplant (109)
  5. CTCR Scholars (54)
  6. Pediatrics, Department of (49)
  7. Survivorship Research (45)
  8. Stem Cell Transplantation and Cellular Therapy Service (43)
  9. MSK Grad Students (42)
  10. Master of Science in Clinical and Translational Cancer Research (41)
Search Within
  1. "Transplantation and Cellular Therapy"
Formats
  1. Journal Article (85)
  2. Meeting Abstract (53)
  3. Guidelines (30)
  4. Review (15)
  5. Editorial (13)
Groups
  1. Department of Medicine (151)
  2. Hematologic Malignancies, Division of (126)
  3. Center for Hematologic Malignancies (120)
  4. Bone Marrow Transplant (109)
  5. CTCR Scholars (54)
  6. Pediatrics, Department of (49)

More Groups

People
  1. Miguel-Angel Perales (66)
  2. Sergio Giralt (36)
  3. Sean Devlin (25)
  4. Parastoo Dahi (24)
  5. Gunjan Shah (23)
  6. Genovefa Papanicolaou (21)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (31)
  4. 2022 (82)
  5. 2021 (40)
Publications
  1. Transplantation and Cellular Therapy (196)

Results (196)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Dendritic cell/multiple myeloma (MM) fusion vaccine with lenalidomide maintenance after autologous hematopoietic cell transplant (HCT) induces MM-specific immunity, BMT CTN 1401
    Meeting Abstract

    Chung, D. J.; Shah, N.; Stroopinsky, D.; Wu, J.; Bisharat, L.; Callander, N. S.; Logan, B.; Anderson, K. C.; Dhakal, B; Devine, S. M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose granulocyte colony stimulating factor mobilization in familial haploidentical adult donors with sickle cell trait followed by CD34+ cell enrichment and mononuclear cell add-back prior to haploidentical allogeneic transplantation in high-risk sickle cell disease recipients
    Meeting Abstract

    Milner, J.; Flower, A.; Schulman, S.; Keever-Taylor, C. A.; Fabricatore, S.; Morris, E.; Mahanti, H.; Shi, Q.; Shaw, R.; Weinberg, R. S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Creation of a new search prognosis tool that can accurately predict the likelihood of procuring an 8/8 HLA-allele matched unrelated donor (URD) in patients of both European and non-European ancestry
    Meeting Abstract

    Davis, E.; Archer, A.; Nhaissi, M.; Rapoport, C.; Suri, B.; Wells, D. S.; Fingrut, W.; Giralt, S. A.; Perales, M. A.; Papadopoulos, E. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • IL-22 treatment overcomes corticosteroid-mediated suppression of epithelial regeneration and exacerbation of gvhd-associated GI damage
    Meeting Abstract

    Arnhold, V.; Jansen, S. A.; Chang, W.; Thangavelu, G.; Vinci, P.; Takashima, S.; Egorova, A.; Kuttiyara, J.; Liu, C.; Calafiore, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save